Poplar Point Capital Management LLC
10% Owner

Poplar Point Capital Management LLC insider trades: NovaBay Pharmaceuticals (NBY) stock buys and sales

10% Owner, NovaBay Pharmaceuticals Last trade Apr 8, 2025 13 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2014
4
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Poplar Point Capital Management LLC reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 8, 2025NBY↑ Buy$16K
Apr 1, 2025NBY↑ Buy$75K
Mar 25, 2025NBY↑ Buy$31K
Mar 18, 2025NBY↑ Buy$40K
Mar 7, 2025NBY↑ Buy$30K
Feb 24, 2025NBY↑ Buy$56K
Jan 31, 2025NBY↑ Buy$68K
May 17, 2016SWSH↑ Buy$17K
May 16, 2016SWSH↓ Sell$97K
May 9, 2016SWSH↓ Sell$289K
Aug 3, 2015SCMR↓ Sell$1.7M
Jul 1, 2015EMRI↑ Buy$183K
Oct 10, 2014SCMR↑ Buy$336K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Poplar Point Capital Management LLC's insider trades

Poplar Point Capital Management LLC is a 10% owner of NovaBay Pharmaceuticals (NBY). Since Oct 10, 2014, it has reported 10 open-market purchases worth $850K and 3 sales worth $2.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NBY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.